J0135 — Injection, adalimumab, 20 mg
J0135 is a HCPCS Level II code for injection, adalimumab, 20 mg. It belongs to the Drugs Administered Other Than Oral Method section. It was terminated on December 31, 2024 and is not valid on new claims.
This code has been terminated
CMS terminated J0135 on December 31, 2024. It stays in the file as history — a claim you are auditing from before that date may legitimately carry it — but it must not appear on a new claim. The adjacent codes below are the usual place to look for its replacement.
Medicare coverage: Carrier judgment
Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
The CMS record for J0135
- Long descriptor
- Injection, adalimumab, 20 mg
- Short descriptor
- Adalimumab injection
- Added
- January 1, 2005
- Terminated
- December 31, 2024
- BETOS
- O1E
- Pricing indicator
- 51 — Other
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
When CMS retired it.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Drugs.
Codes adjacent to J0135
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J0135 is not quite right, the correct code is very often within a few positions of it.
- J0121Injection, omadacycline, 1 mg
- J0122Injection, eravacycline, 1 mg
- J0129Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
- J0130Injection abciximab, 10 mg
- J0131Injection, acetaminophen, not otherwise specified,10 mg
- J0132Injection, acetylcysteine, 100 mg
- J0133Injection, acyclovir, 5 mg
- J0134Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg
- J0136Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg
- J0137Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg
- J0138Injection, acetaminophen 10 mg and ibuprofen 3 mg
- J0139Injection, adalimumab, 1 mg
- J0150Injection, adenosine for therapeutic use, 6 mg (not to be used to report any adenosine phosphate compounds, instead use a9270)terminated
- J0151Injection, adenosine for diagnostic use, 1 mg (not to be used to report any adenosine phosphate compounds, instead use a9270)terminated
- J0153Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)
- J0162Injection, epinephrine (fresenius), not therapeutically equivalent to j0165, 0.1 mg
Questions about J0135
What is HCPCS code J0135?
J0135 is a HCPCS Level II code for injection, adalimumab, 20 mg. It sits in the Drugs Administered Other Than Oral Method section.
Does Medicare cover J0135?
The CMS HCPCS file marks J0135 as "Carrier judgment". Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
Is J0135 still valid?
No. J0135 was terminated on December 31, 2024 and should not be used on new claims.